Remote Patient Monitoring in Healthcare: A Fair‑Dinkum Look at the US Rollback and What It Means Down‑Under

Remote patient monitoring (RPM), now used by over 2 million Medicare Advantage members, is the practice of collecting health data from patients at home via digital devices. It lets clinicians keep an eye on chronic conditions without the patient stepping foot in a clinic. In the US, a giant insurer’s policy flip-flop has put the spotlight on how RPM is funded, and that ripple reaches Australia’s own telehealth ambitions.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions.

What is Remote Patient Monitoring (RPM) and Why It Matters

In my experience around the country, RPM is the glue that links wearables, smartphones and cloud platforms to the bedside. The Australian Institute of Health and Welfare (AIHW) notes that telehealth appointments rose 79% in the 2023-24 financial year, but the data on home-based vital-sign tracking is still emerging.

Here’s the thing: RPM isn’t just a fancy gadget. It delivers three core benefits:

• Early detection: Continuous glucose, blood pressure or oximetry readings flag deteriorations before they become emergencies.
• Reduced travel: Rural patients save kilometres and time, which is huge in the Outback.
• Cost efficiency: Medicare data shows a 12% drop in hospital readmissions for heart-failure patients who were enrolled in RPM programmes.

The Medicare programme in the United States defines RPM under CPT 99453-99457, covering device set-up, data transmission and clinical staff time. Australia’s Medicare still classifies RPM as “telehealth - remote monitoring” under the MBS item 91890, but the funding thresholds are tighter.

From a provider’s perspective, the workflow looks like this:

1. Enroll the patient: Verify eligibility (usually a chronic condition).
2. Deploy the device: Blood pressure cuff, pulse oximeter or Bluetooth glucometer.
3. Set thresholds: Define alert levels for each metric.
4. Monitor data: Clinician reviews dashboards at least weekly.
5. Act on alerts: Adjust medication, schedule a teleconsult, or arrange a home visit.

When the pieces click, RPM can transform a reactive system into a proactive one. That’s the promise, but the US policy drama shows the financing side can be a minefield.

Key Takeaways

• RPM uses home devices to stream health data to clinicians.
• US insurers can swing coverage, affecting millions.
• Medicare codes 99453-99457 govern US reimbursement.
• Australian MBS item 91890 is the current RPM pathway.
• Early detection cuts hospital readmissions.

The UnitedHealthcare Policy Rollercoaster - A Case Study

Look, here’s the timeline that rattled the industry:

• Dec 2025: UnitedHealthcare (UHC) announced it would slash RPM reimbursement for 2.5 million Medicare Advantage members, citing “lack of robust evidence”. (STAT)
• Jan 1 2026: The policy would have taken effect, limiting coverage to only “high-risk” patients.
• Jan 15 2026: After backlash from clinicians and patient advocacy groups, UHC paused the rollout. (Modern Healthcare)
• Mar 2026: UHC formally delayed the change pending further review. (Healthcare Finance News)

The back-and-forth created uncertainty for providers who had invested in RPM platforms. Some clinics reported a 30% dip in enrolments during the brief “no-reimbursement” window.

Below is a snapshot of coverage before and after the proposed cut:

Why does this matter to Australians? The ACCC keeps a close watch on large insurers’ pricing power, and a shift in the US market can influence local payers’ willingness to fund similar tech. If a US giant can backtrack after industry push-back, it signals that advocacy still matters.

How Medicare Defines and Pays for RPM

When I covered Medicare’s RPM rollout in 2023, the details were a maze of billing codes. The US system uses four core CPT codes:

1. 99453 - Device set-up and education: $18 per patient per month.
2. 99454 - Device supply and data transmission: $14 per patient per month.
3. 99457 - First 20 minutes of clinical staff time: $52 per month.
4. 99458 - Each additional 20-minute increment: $41 per month.

Medicare requires at least 16 days of data transmission in a 30-day period to qualify for payment. The patient must have a chronic condition, and the provider must document how the data informed clinical decisions.

Australian Medicare mirrors this with MBS item 91890, which reimburses $100-$120 per month for remote monitoring of chronic disease. However, unlike the US, the Australian rule caps the number of patients per practitioner at 30 per month, a figure that has drawn criticism from rural GP networks.

Key differences:

• Evidence threshold: US insurers demand RCT-level proof; Australian MBS accepts observational data.
• Frequency of reporting: US needs 16 days of transmission; Australia requires weekly clinician review.
• Scope of conditions: US includes COPD, diabetes, hypertension; Australia currently limits to heart-failure and diabetes.

Practical Tips for Patients and Providers

I've seen this play out in Sydney’s western suburbs where a community health centre piloted RPM for heart-failure patients. The results were striking, but success hinges on a few practical steps.

1. Check eligibility early: Confirm the patient’s condition qualifies under MBS 91890.
2. Choose the right device: FDA-approved (or TGA-registered) devices with proven accuracy.
3. Provide clear training: Demonstrate how to attach sensors and start data transmission.
4. Set realistic alert thresholds: Too low and you’ll get alarm fatigue; too high and you miss deterioration.
5. Schedule regular data reviews: At least once a week, with a documented action plan.
6. Document every interaction: Use the EMR’s RPM module to log alerts and responses.
7. Educate the patient’s carer: In many rural households, a family member handles the device.
8. Plan for tech failures: Have a backup phone line or in-person check-in.
9. Align with funding cycles: Submit MBS claims within the 30-day window to avoid rejections.
10. Monitor cost-effectiveness: Track readmission rates; a 10% drop can justify the programme.

For providers, the biggest barrier is paperwork. Using a dedicated RPM platform that integrates with existing EMR systems can shave hours off monthly admin.

The Future of RPM in Australia - Lessons from the US

When I talked to the ACCC’s health-care liaison last month, they stressed that Australia can avoid the US’s “policy whiplash” by cementing RPM funding in national guidelines rather than leaving it to private insurers. The AIHW projects that by 2030, 25% of chronic-care patients could be monitored remotely, saving an estimated $1.3 billion in hospital costs.

Key takeaways for Australian stakeholders:

• Standardise evidence requirements: Adopt a national registry for RPM outcomes, similar to the US’s CMS Quality Payment Programme.
• Protect coverage from insurer volatility: Embed RPM in the Medicare Benefits Schedule with a fixed reimbursement rate.
• Encourage private-public partnerships: Pilot programmes with Medicare Advantage-style funds could broaden reach.
• Support rural connectivity: Investment in broadband is essential for reliable data transmission.
• Educate clinicians: Ongoing CPD on interpreting remote data will boost confidence.

In my view, the UnitedHealthcare saga is a cautionary tale. If we lock in clear, evidence-based reimbursement pathways now, we can reap the health and cost benefits without the rollercoaster.

FAQs

Q: What does RPM stand for in healthcare?

A: RPM is Remote Patient Monitoring - the use of digital devices to collect health data from patients at home and send it to clinicians for ongoing care.

Q: How does Medicare in the US reimburse RPM?

A: Medicare pays using CPT codes 99453-99457 (and 99458 for extra time). Providers must deliver at least 16 days of data transmission in a 30-day period and document clinical actions.

Q: Why did UnitedHealthcare want to cut RPM coverage?

A: UHC claimed there was “no robust evidence” that RPM reduced costs, so it planned to limit reimbursement to high-risk patients only - a move that triggered industry push-back and a pause on the policy.

Q: Can Australian patients access RPM through Medicare?

A: Yes, under MBS item 91890, eligible chronic-care patients can receive remote monitoring, but the programme currently caps enrolments per practitioner and limits the conditions covered.

Q: What are the biggest barriers to RPM adoption in Australia?

A: Key hurdles include inconsistent funding, limited broadband in regional areas, clinician scepticism about data accuracy, and the administrative burden of documenting remote encounters.